COVID-19 Boosters
Over 4 years since the start of COVID-19 and the virus is still circulating. There have been numerous updates to vaccines and recommendations along the way. As we head into the cooler months, here are the newest recommendations for COVID-19 Boosters in 2024:
75 years and older
- Recommended every 6 months.
65-74 years
- Recommended at least every 12 months, but can receive every six months. Talk to your healthcare provider about the risks and benefits..
18-64 years
- With severe immunocompromise: Recommended at least every 12 months, but can receive every six months. Talk to your healthcare provider about the risks and benefits.
- Without severe immunocompromise: Can receive every 12 months.
5-17 years
- With severe immunocompromise: Can receive every 12 months.
- Without severe immunocompromise: Not recommended.
Under 5 years
- Not recommended.
COVID-19 Boosters can be booked online or contact our reception to make an appointment. Flushots can be administered together safely with COVID-19 immunisations.
There continues to be no out of pocket cost for COVID-19 immunisations.
2024 Influenza Immunisations
Flushots are available from April 2024. Influenza continues to be a common illness causing hospitalisation for young and old.
Similar to previous years, the flushot is government funded for the following people:
– All people aged 65 years and over
– Children aged 6 monthes to less than 5 years of age
– Aboriginal and Torres Strait Islander people aged 6 months and over
– Pregnant people
– People aged 6 monhts of age or over with certain medical conditions, including:
- cardiac disease
- chronic respiratory conditions (including severe asthma)
- chronic neurological conditions that increase the risk of respiratory infection (including hereditary and degenerative central nervous system diseases and seizure disorders)
- immunocompromising conditions (including immunocompromised due to disease or treatment)
- diabetes and other metabolic disorders
- renal disease
- haematological disorders (including haemoglobinopathies)
- children aged six months to 10 years on long term aspirin therapy who are at increased risk of Reye syndrome following influenza infection.